Wells Fargo Upgrades GLUE, Jefferies Downgrades GBIO
Wells Fargo upgrades Monte Rosa Therapeutics on 2026 catalysts, while Jefferies downgrades Generation Bio due to its pending acquisition by Xoma.
NOTRELOAD AI
KeyBanc Turns Cautious on GitLab as Pricing Pressure Looms
KeyBanc downgraded GitLab to Sector Weight, citing pricing pressure, business model changes, and balanced risk/reward at current levels.
Aldeyra's Dry Eye Treatment Gets FDA Review Extension
Aldeyra Therapeutics (ALDX) receives FDA extension for reproxalap dry eye drug review. New decision date set for March 2026 as agency requests additional trial documentation.
Morgan Stanley Upgrades Roku as Connected TV Ads Gain Momentum
Morgan Stanley upgrades Roku to Overweight, raises price target to $135, and highlights strong growth ahead for connected TV advertising.
ReNu Knee Treatment Moves Forward with FDA Approval Process
Organogenesis receives FDA clearance to file for approval of ReNu, a regenerative treatment for knee osteoarthritis pain affecting millions of Americans.
PayPal Applies to Become a US Bank Under Trump Administration
PayPal has filed applications to establish PayPal Bank, a Utah-chartered industrial loan company, aiming to expand small-business lending and offer savings accounts to customers.